Application of 99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma
Application of 99mTc labeled chimeric Fab fragments of monoclonal antibody A7 for immunoscintigraphy of pancreatic carcinoma
复制标题
DOI:
10.1002/jso.10311
复制
发表时间:
2003-11-01
影响因子:
2.5
通讯作者:
Yamagishi, H
中科院分区:
文献类型:
--
作者:
Otsuji, E;Matsumura, H;Yamagishi, H
Background: One of the reasons for the poor prognosis of pancreatic carcinoma is the difficulty of obtaining an early diagnosis of pancreatic carcinoma. One possibility is the application of radioimmunoscintigraphy using radiolabeled monoclonal antibodies (Mabs).Methods: We labeled chimeric (human/mouse) Fab fragments of Mab A7 (chA7Fab) with Tc-99m and examined the distribution of Tc-99m-labeled chA7Fab in nude mice bearing human pancreatic carcinoma.Results: The tumor accumulation of Tc-99m-labeled chA7Fab was larger than that of Tc-99m-labeled A7 from 2 to 6 hr after injection. Tc-99m-labeled chA7Fab disappeared from blood more rapidly than Tc-99m-labeled AT For all resected normal tissues except kidney, the accumulation of Tc-99m-labeled chA7Fab was low and similar to that of Tc-99m-labeled A7.Conclusions: Because the half-life of Tc-99m is short (6 hr), chA7Fab, which accumulates rapidly in tumors, may be a better carrier of Tc-99m than intact Mab A7. (C) 2003 Wiley-Liss, Inc.